Researchers report the results obtained from the use of a new PRS calculator called CT-SLEB on a multi-national GWAS database.
Pfizer plans another $500M in cost cuts, expects $3.1B in revenue from Seagen in 2024
Pfizer’s not-so-good year continues. The New York pharma giant’s shares $PFE slid 7% before Wednesday’s opening bell after Pfizer said it plans to cut another